Vital Signs Prediction for COVID-19 Patients in ICU.


Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
05 Dec 2021
Historique:
received: 08 11 2021
revised: 29 11 2021
accepted: 30 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

This study introduces machine learning predictive models to predict the future values of the monitored vital signs of COVID-19 ICU patients. The main vital sign predictors include heart rate, respiration rate, and oxygen saturation. We investigated the performances of the developed predictive models by considering different approaches. The first predictive model was developed by considering the following vital signs: heart rate, blood pressure (systolic, diastolic and mean arterial, pulse pressure), respiration rate, and oxygen saturation. Similar to the first approach, the second model was developed using the same vital signs, but it was trained and tested based on a leave-one-subject-out approach. The third predictive model was developed by considering three vital signs: heart rate (HR), respiration rate (RR), and oxygen saturation (SpO2). The fourth model was a leave-one-subject-out model for the three vital signs. Finally, the fifth predictive model was developed based on the same three vital signs, but with a five-minute observation rate, in contrast with the aforementioned four models, where the observation rate was hourly to bi-hourly. For the five models, the predicted measurements were those of the three upcoming observations (on average, three hours ahead). Based on the obtained results, we observed that by limiting the number of vital sign predictors (i.e., three vital signs), the prediction performance was still acceptable, with the average mean absolute percentage error (MAPE) being 12%,5%, and 21.4% for heart rate, oxygen saturation, and respiration rate, respectively. Moreover, increasing the observation rate could enhance the prediction performance to be, on average, 8%,4.8%, and 17.8% for heart rate, oxygen saturation, and respiration rate, respectively. It is envisioned that such models could be integrated with monitoring systems that could, using a limited number of vital signs, predict the health conditions of COVID-19 ICU patients in real-time.

Identifiants

pubmed: 34884136
pii: s21238131
doi: 10.3390/s21238131
pmc: PMC8662454
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

PLoS One. 2019 Jan 15;14(1):e0210875
pubmed: 30645637
Resuscitation. 2004 Sep;62(3):275-82
pubmed: 15325446
Scand J Trauma Resusc Emerg Med. 2012 Apr 10;20:28
pubmed: 22490208
PLoS One. 2021 Jul 2;16(7):e0252384
pubmed: 34214101
Sensors (Basel). 2020 Nov 18;20(22):
pubmed: 33218084
Resuscitation. 2018 Dec;133:75-81
pubmed: 30253229

Auteurs

Ahmed Youssef Ali Amer (A)

E-MEDIA, STADIUS, Department of Electrical Engineering (ESAT), Campus Group T, KU Leuven, 3000 Leuven, Belgium.
Measure, Model & Manage Bioresponses (M3-BIORES), Department of Biosystems, KU Leuven, 3000 Leuven, Belgium.

Femke Wouters (F)

Limburg Clinical Research Center/Mobile Health Unit, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
Limburg Clinical Research Center/Mobile Health Unit, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Anesthesiology, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Cardiology and Future Health, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.

Julie Vranken (J)

Limburg Clinical Research Center/Mobile Health Unit, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
Limburg Clinical Research Center/Mobile Health Unit, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Anesthesiology, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Cardiology and Future Health, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.

Pauline Dreesen (P)

Limburg Clinical Research Center/Mobile Health Unit, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
Limburg Clinical Research Center/Mobile Health Unit, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Anesthesiology, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Cardiology and Future Health, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.

Dianne de Korte-de Boer (D)

Department of Anesthesiology and Pain Management, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands.

Frank van Rosmalen (F)

Department of Intensive Care, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands.

Bas C T van Bussel (BCT)

Department of Intensive Care, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands.

Valérie Smit-Fun (V)

Department of Anesthesiology and Pain Management, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands.

Patrick Duflot (P)

Service des Applications Informatiques, Centre Hospitalier Universitaire de Liège-CHU, 4000 Liège, Belgium.

Julien Guiot (J)

Respiratory Medicine, Centre Hospitalier Universitaire de Liège-CHU, 4000 Liège, Belgium.

Iwan C C van der Horst (ICC)

Department of Intensive Care, Maastricht University Medical Centre+, 6229 HX Maastricht, The Netherlands.

Dieter Mesotten (D)

Limburg Clinical Research Center/Mobile Health Unit, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
Limburg Clinical Research Center/Mobile Health Unit, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Anesthesiology, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Cardiology and Future Health, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.

Pieter Vandervoort (P)

Limburg Clinical Research Center/Mobile Health Unit, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
Limburg Clinical Research Center/Mobile Health Unit, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Anesthesiology, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.
Department of Cardiology and Future Health, Ziekenhuis Oost-Limburg, 3600 Genk, Belgium.

Jean-Marie Aerts (JM)

Measure, Model & Manage Bioresponses (M3-BIORES), Department of Biosystems, KU Leuven, 3000 Leuven, Belgium.

Bart Vanrumste (B)

E-MEDIA, STADIUS, Department of Electrical Engineering (ESAT), Campus Group T, KU Leuven, 3000 Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH